NBIX
Neurocrine Biosciences, Inc.
Revenue to net incomeLast 12 months
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | $3.7B | +22.3% |
| Gross profit | $3.6B | +22.1% |
| Operating income | $887M | +30.6% |
| Net income | $703M | +3.3% |
| EPS | $6.74 | +2.3% |
| Free cash flow | $749M2025 | +28.0% |